Roe D - Search Results

1

Smoking exposure as a risk factor for prevalent and recurrent colorectal adenomas.

Reid ME, Marshall JR, Roe D, Lebowitz M, Alberts D, Battacharyya AK, Martinez ME. Reid ME, et al. Among authors: roe d. Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):1006-11. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14578135

2

Antitumor activity and clinical pharmacology of sulofenur in ovarian cancer.

Taylor CW, Alberts DS, Peng YM, McCloskey TM, Matzner M, Roe DJ, Plezia PM, Grindey GB, Hamilton M, Seitz D. Taylor CW, et al. Among authors: roe dj. J Natl Cancer Inst. 1992 Dec 2;84(23):1798-802. doi: 10.1093/jnci/84.23.1798. J Natl Cancer Inst. 1992. PMID: 1433369 Clinical Trial.

3

Lack of ranitidine effects on cyclophosphamide bone marrow toxicity or metabolism: a placebo-controlled clinical trial.

Alberts DS, Mason-Liddil N, Plezia PM, Roe DJ, Dorr RT, Struck RF, Phillips JG. Alberts DS, et al. Among authors: roe dj. J Natl Cancer Inst. 1991 Dec 4;83(23):1739-42. doi: 10.1093/jnci/83.23.1739. J Natl Cancer Inst. 1991. PMID: 1770553 Clinical Trial.

4

Phase I clinical and pharmacokinetic study of mitoxantrone given to patients by intraperitoneal administration.

Alberts DS, Surwit EA, Peng YM, McCloskey T, Rivest R, Graham V, McDonald L, Roe D. Alberts DS, et al. Among authors: roe d. Cancer Res. 1988 Oct 15;48(20):5874-7. Cancer Res. 1988. PMID: 3167842

5

Predictive model for plasma concentration-versus-time profiles of investigational anticancer drugs in patients.

Davis LE, Alberts DS, Plezia PM, Roe DJ, Griswold DP. Davis LE, et al. Among authors: roe dj. J Natl Cancer Inst. 1988 Aug 3;80(11):815-9. doi: 10.1093/jnci/80.11.815. J Natl Cancer Inst. 1988. PMID: 3392741

6

Plasma pharmacokinetics of cyclophosphamide and its cytotoxic metabolites after intravenous versus oral administration in a randomized, crossover trial.

Struck RF, Alberts DS, Horne K, Phillips JG, Peng YM, Roe DJ. Struck RF, et al. Among authors: roe dj. Cancer Res. 1987 May 15;47(10):2723-6. Cancer Res. 1987. PMID: 3552204 Clinical Trial.

7

Comparison of proliferating cell nuclear antigen versus the more standard measures of rectal mucosal proliferation rates in subjects with a history of colorectal cancer and normal age-matched controls.

Einspahr J, Alberts D, Xie T, Ritchie J, Earnest D, Hixson L, Powell M, Roe D, Grogan T. Einspahr J, et al. Among authors: roe d. Cancer Epidemiol Biomarkers Prev. 1995 Jun;4(4):359-66. Cancer Epidemiol Biomarkers Prev. 1995. PMID: 7655331

8

Validation of proliferation indices as surrogate endpoint biomarkers.

Alberts DS, Einspahr J, Aickin M, Hixson L, Earnest D, Roe D, Powell M. Alberts DS, et al. Among authors: roe d. J Cell Biochem Suppl. 1994;19:76-83. J Cell Biochem Suppl. 1994. PMID: 7823609 Clinical Trial.

9

Reproducibility of the measurement of colonic proliferation using bromodeoxyuridine across laboratories.

Roe DJ, Alberts DS, Wargovich MJ, Bostick RM, Garewal HS, Einspahr J, Fosdick L, Ramsey L, Woods C, McGee DL. Roe DJ, et al. Cancer Epidemiol Biomarkers Prev. 1996 May;5(5):349-53. Cancer Epidemiol Biomarkers Prev. 1996. PMID: 9162300

10

Safety of autotransplants with high-dose melphalan in renal failure: a pharmacokinetic and toxicity study.

Tricot G, Alberts DS, Johnson C, Roe DJ, Dorr RT, Bracy D, Vesole DH, Jagannath S, Meyers R, Barlogie B. Tricot G, et al. Among authors: roe dj. Clin Cancer Res. 1996 Jun;2(6):947-52. Clin Cancer Res. 1996. PMID: 9816255

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

788 results

Search Page

Filters